@misc{indiciae7c2a23f80cb9,
  title = {Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial.},
  author = {S R Steinhubl and S G Ellis and K Wolski and A M Lincoff and E J Topol},
  year = {2001},
  doi = {10.1161/01.cir.103.10.1403},
  url = {https://pubmed.ncbi.nlm.nih.gov/11245644/},
  note = {Source identifier: 11245644}
}